GlassScriptPhysician profile
James J Lynch
NPI 1942291810
$111,996.23
in general payments reported to CMS, 2019-2025
13 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $596 · 2020: $27.35 · 2021: $48K · 2022: $63K · 2023: $145 · 2024: $300 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $568.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $568.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $109,998.48 | 2021-2022 | |
| Augmedics INC. | $355.65 | 2020-2022 | |
| Globus Medical, INC. | $345.25 | 2019 | |
| Seaspine Orthopedics Corporation | $333.75 | 2022 | |
| Orthofix Medical, INC. | $201.01 | 2024 | Lattus, Shoreline Asc |
| Depuy Synthes Sales INC. | $162.44 | 2019-2022 | |
| Stryker Corporation | $159.53 | 2019 | |
| Siemens Medical Solutions USA, INC. | $145.79 | 2023-2024 | Magnetom Free.Max |
| Itamar Medical INC | $97.99 | 2023 | Watchpatone |
| Edwards Lifesciences Corporation | $96.15 | 2025 | Pascal |
| Integra Lifesciences Corporation | $72.74 | 2019-2020 | |
| Arthrex, INC. | $27.45 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,476,643.21 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Lynch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.